Surgical Gloves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The surgical gloves market size was valued at USD 5.04 billion in 2025 and estimated to grow from USD 5.26 billion in 2026 to reach USD 6.54 billion by 2031, at a CAGR of 4.44% during the forecast period (2026-2031). This report is Segmented by Material (Nitrile, Latex, Neoprene, Polyisoprene and More), Form (Powdered and Powder-Free), End-User (Hospitals, Ambulatory Surgical Centers, Clinics & Physician Offices, Dental & Veterinary Facilities and Others) and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Surgical Gloves Market Trends and Insights

Surge in Global Surgical Procedures

Elective, trauma, and outpatient surgeries continue to climb as life expectancy rises and minimally invasive techniques shorten recovery time. Sg2 projects that ASC procedure volume will expand 21% to hit 44 million cases by 2034, more than offsetting lower glove consumption per case than inpatient settings. Orthopedic and spine operations dominate this wave, demanding gloves with high puncture resistance and tactile feedback. Despite tight global supplies, the Malaysian Rubber Glove Manufacturers Association (MARGMA) forecasts a shortfall of 80 billion pieces in 2024. Demand is set to reach 500 billion pieces, but installed capacity is only at 420 billion. This gap not only sustains pricing power but also encourages measured capacity additions, steering clear of speculative oversupply. Hospitals keep complex cases, preserving premium glove demand, while cost-sensitive ASCs lean toward bulk purchasing contracts that bundle high-usage items. Overall, the surgical gloves market benefits from volume growth even as unit cost pressure intensifies.

Stringent Workplace Safety Mandates in Emerging Markets

Governments from India to Indonesia are tightening personal protective equipment (PPE) rules that parallel European norms, making certified surgical gloves mandatory in operating theaters and high-risk industrial zones. The World Intellectual Property Organization (WIPO) records a 26.4% CAGR in occupational-health tech patents between 2018 and 2023, underscoring regulatory momentum. Enforcement is shifting from paper audits to digital monitoring, creating steady rather than sporadic glove demand. Domestic-content stipulations encourage local manufacturing, yet quality variances across plants necessitate strict supplier audits by global buyers.

Raw-Material Price Volatility

Natural rubber latex (NRL) surged to a 13-year price high in October 2024 after heavy rains hammered Thai and Chinese plantations, squeezing margins for glove makers reliant on Southeast Asian supply. Simultaneous shortages of nitrile butadiene rubber in the United States prompted federal waivers for foreign sourcing until at least late 2025. Producers pass some costs to buyers, yet long-term contracts cap price flexibility, pressuring EBITDA margins. Diversifying into guayule or Scorzonera tau-saghyz remains at pilot scale, leaving the surgical gloves market exposed to commodity swings.

Other drivers and restraints analyzed in the detailed report include:

• Shift Toward Powder-Free & Accelerator-Free Chemistries
• Adoption of E-Commerce Procurement by Hospitals & ASCs
• Latex Allergy Concerns & Regulatory Bans

Segment Analysis

The surgical gloves market have latex occupying 38.70% of surgical gloves market share on the strength of low cost and proven performance. Yet hospitals are migrating toward latex-free operating rooms, propelling polyisoprene to a 4.96% CAGR through 2031. Molecular-dynamics studies peg polyisoprene’s glass-transition temperature at 204.2 K, balancing flexibility and tear resistance - traits valued in microsurgery. Manufacturers add antioxidant packages to curb discoloration, and accelerator-free curing lowers Type IV allergy risk. Nitrile keeps traction in examination settings, while neoprene fills chemical-resistant niches such as oncology compounding. Sustainable sourcing is gaining ground; Top Glove’s BioGreen nitrile gloves biodegrade under anaerobic landfill conditions, aligning with hospital waste-reduction mandates.

In procurement bids, buyers now score materials on a weighted matrix of allergenicity, tactile response, environmental footprint, and price. This shift favors vertically integrated suppliers that control latex tapping, compounding, and finished-goods molding because they can adjust formulations quickly. Regional contract awards in India and Indonesia increasingly require localized raw-rubber content, nudging multinationals to joint ventures or toll-manufacturing deals. The resulting tactical alliances will shape capacity additions over the next cycle in the surgical gloves market.

Complete Report Scope:

• By Material
  • Latex
  • Nitrile
  • Neoprene
  • Polyisoprene
  • Others (Vinyl and Synthetic blends, among others)
• By Form
  • Powdered
  • Powder-free
• By End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics & Physician Offices
  • Dental & Veterinary Facilities
  • Others (Emergency Centers, among others)
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

North America generated 34.10% of global revenue in 2025 and remains the procurement standard-setter due to a mature hospital network, robust infection-control guidelines, and group-purchasing organizations that mandate ASTM compliance. U.S. federal agencies alone ordered 55.5 million boxes of nitrile gloves in 2025 as part of domestic-stockpile programs. Tariff pressures and geopolitical risk from China have revived interest in near-shoring to Mexico and Puerto Rico. To fortify resilience, Cardinal Health invested USD 340 million in an automation-heavy distribution hub that supports one-day delivery to 80% of U.S. surgical sites.

Asia-Pacific is advancing at a 5.26% CAGR through 2031, reflecting rising surgical infrastructure and the region’s dual identity as both supply base and demand center. Malaysia and Thailand produce roughly two-thirds of the world’s surgical gloves, yet Thai research flags persistent labor shortages and climate-change exposure that could disrupt latex tapping seasons. China’s elective-surgery rebound post-zero-COVID adds a substantial incremental volume, while India’s Ayushman Bharat insurance scheme continues to unlock latent demand in tier-2 cities. Local content rules in Indonesia and Vietnam encourage foreign brands to build or partner in-country, altering the competitive map of the surgical gloves market.

Europe maintains stable mid-single-digit growth, driven by sustainability regulations and a push for circular-economy compliance. Mölnlycke’s EUR 50 million Malaysian plant includes biomass boilers and solar rooftops to satisfy EU carbon-footprint reduction targets. The bloc’s EcoDesign directive will likely require material passports, amplifying interest in blockchain traceability. South America and the Middle East & Africa trail but offer long-run potential once macroeconomic volatility settles; Brazil’s new PPP program for hospital upgrades and Saudi Arabia’s Vision 2030 private-hospital wave represent catalysts, albeit from a low base. Logistics bottlenecks and currency swings remain obstacles that suppliers must price into long-term contracts.

List of Companies Covered in this Report:

• Ansell
• Asma Rubber Products Pvt. Ltd.
• Cardinal Health
• Cranberry Global
• Dynarex
• Globus (Shetland) Ltd.
• Hartalega Holdings
• Kanam Latex Industries
• Kossan Rubber Industries
• Medline Industries
• Molnlycke Health Care
• Shandong Intco Medical Products
• Sri Trang Gloves Plc
• Supermax
• Top Glove
• Unigloves (UK) Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support